← Back to Search

FaceView Mask™ Usability for Individuals With Hearing Loss

N/A

Waitlist Available

Led By Samuel R Atcherson, PhD

Research Sponsored by University of Arkansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 day

Awards & highlights

Study Summary

This trial will test how well a new, transparent surgical mask works compared to a conventional one.

Who is the study for?

This trial is for adults over 18 who can read and communicate in English or American Sign Language, with no health conditions like severe asthma that would prevent safe use of an N95 respirator. Participants must provide their own transport to the study site.Check my eligibility

What is being tested?

The study compares perceptions of a new transparent surgical N95 mask (FaceView Mask™) versus a conventional one. After fitting the masks, participants will answer questions about fit, comfort, ease of use, and communication benefits.See study design

What are the potential side effects?

There are no direct side effects from participating in this trial as it involves wearing different types of masks and providing feedback rather than testing a medical treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 day

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 day

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

ease of understanding another person

Secondary outcome measures

comfort of the mask

ease of breathing

ease of speaking/communicating

+1 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: All SubjectsExperimental Treatment2 Interventions

All participants will be fit tested for the masks to ensure that the appropriate size is used. Some participants will wear the FaceView Mask™ (first) for 5 minutes before wearing the conventional surgical N95 respirator for 5 minutes. Others will wear the conventional surgical N95 respirator (first) for 5 minutes before wearing the FaceView Mask™ for 5 minutes. All subjects will complete the study survey after exposure to the interventions.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

FaceView Mask™

2022

N/A

~210

conventional surgical N95 respirator

2022

N/A

~210

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor

486 Previous Clinical Trials

150,151 Total Patients Enrolled

4 Trials studying Hearing Loss

20,474 Patients Enrolled for Hearing Loss

Samuel R Atcherson, PhDPrincipal InvestigatorUniversity of Arkansas

Media Library

conventional surgical N95 respirator Clinical Trial Eligibility Overview. Trial Name: NCT04854694 — N/A

Hearing Loss Research Study Groups: All Subjects

Hearing Loss Clinical Trial 2023: conventional surgical N95 respirator Highlights & Side Effects. Trial Name: NCT04854694 — N/A

conventional surgical N95 respirator 2023 Treatment Timeline for Medical Study. Trial Name: NCT04854694 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment for this exploration still available?

"As evidenced by clinicaltrials.gov, this medical trial has been suspended from recruiting new candidates since the 9th of December 2022. The study was originally posted on November 1st, 2022 and at present 4 other trials are actively searching for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Product Testing of the FaceView Mask™: Usability Survey

2022. "Product Testing of the FaceView Mask™: Usability Survey". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04854694.